- Home
- FULTP vs FBIOP Comparison
FULTP vs FBIOP Comparison
Compare FULTP & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
FULTP
Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Current Price
Company Overview
Basic Information| Metric | FULTP | FBIOP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 1995 | 2011 |
Fundamental Metrics
Financial Performance| Metric | FULTP | FBIOP |
|---|---|---|
| Price | $17.47 | $19.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 14.0K | 9.7K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | 32.48 | ★ 97.40 |
| EPS | 1.02 | ★ 2.82 |
| Revenue | ★ $276,768,000.00 | $63,262,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 9.69 |
| 52 Week Low | $17.40 | $6.27 |
| 52 Week High | $20.83 | $21.43 |
Technical Indicators
Market Signals| Indicator | FULTP | FBIOP |
|---|---|---|
| Relative Strength Index (RSI) | 38.97 | 48.35 |
| Support Level | N/A | $17.90 |
| Resistance Level | $18.76 | $21.33 |
| Average True Range (ATR) | 0.20 | 0.41 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 22.92 | 36.66 |
Price Performance
Historical ComparisonAbout FULTP Fulton Financial Corporation Depositary Shares Each Representing a 1/40th Interest in a Share of Fixed Rate Non-Cumulative Perpetual Preferred Stock Series A
Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.